A randomized Phase 2 study to evaluate the orexin-2 receptor antagonist seltorexant in individuals with insomnia without psychiatric comorbidity
Year: 2018
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Journal of Psychopharmacology
Institutions: Janssen (Belgium), Janssen Research & Development (United States), Janssen (United States), Siesta Group (Austria), Medical University of Vienna, Leiden University Medical Center, Centre for Human Drug Research, Universitätsmedizin Rostock, Charité – Universitätsmedizin Berlin, University Medical Center Hamburg-Eppendorf, Minerva Neurosciences (United States)
Language: English
Topic: Sleep and related disorders
Subfield: Experimental and Cognitive Psychology
Field: Psychology
Domain: Social Sciences
Open Access status: closed
Funder: Janssen Research and Development
OpenAlex ID: W2807073242